Wednesday, July 8, 2026

pharma · Chronic Lymphocytic Leukemia (CLL) · Chronic Lymphocytic Leukemia · APVO

Aptevo Therapeutics

News and analysis for Aptevo Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

Seattle, USA HQ
2016 Founded
54 Employees
Public company Type
APVO · NYSE Ticker
Company details
Status
Public
HQ
Seattle, USA
Founded
2016
Employees
54
Programs
9
Drugs
4
Patents
13
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Aptevo Therapeutics — regulatory, clinical, and market coverage.

News and analysis for Aptevo Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Aptevo Therapeutics yet.

Back to company overview →